期刊文献+

美国FDA药品生产质量监管体系 被引量:16

US FDA's regulatory system for drug manufacturing quality
原文传递
导出
摘要 美国食品药品监督管理局(Food and Drug Administration,FDA)作为全球药品监管机构的领先者,具备先进的科学和完善的法规体系及合理的机构设置和有效的运行机制。本文针对药品生产质量监管,剖析FDA注册审评、现场检查及合规审评三方面职能,讨论其部门设置和职能划分、运行机制,及资源配置和技术支持,为药监部门加强科学监管提供借鉴,也为企业了解美国FDA药品生产质量监管体系并与其有效沟通提供参考。 As a global leader in pharmaceutical regulation, the US Food and Drug Administration (FDA) is known for its well developed scientific capability, legal and regulatory foundation, organizational setup and opera tional experience. This work analyzes FDA's regulatory system for drug manufacturing quality from the program per spectives of application review, GMP inspection and compliance review by focusing on organizational and functional setup, operational mode, resource allocation and program support. The outcome of this work can serve as a refer ence for regulatory agencies to strenghten sciencebased regulation, and for drug manufacturers to gain program knowledge and improve communication with the FDA
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第18期2128-2136,共9页 Chinese Journal of New Drugs
关键词 药品生产质量 注册审评 现场检查 GMP合规审评 部门设置 运行机制 资源配置 drug manufacturing quality application review compliance review GMP inspection organi-zation operation resource allocation
  • 相关文献

参考文献29

  • 1FDA. Pathway to Global Product Safety and Quality[ S]. 2011.
  • 2FDA. Regulatory Procedures Manual[ S]. 2011.
  • 3FDA. Generic Drug User Fee Act Program Performance Goals and Procedures [ S ]. 2011.
  • 4FDA. Volume I-Organizations and Functions. FDA Staff Manual Guides[ EB/OL]. [2012 -09 -06]. http://www, fda. gov/AboutF- DA/ReportsManualsForms/StaffManualGuides/ucm136374. htm.
  • 5FDA. Organization Charts FDA Overview[ S]. 2012.
  • 6HAMBURG MA. The President's Fiscal Year 2011 Budget Re- quest for FDA. Congressional Testimony, March, 2010. http:// www. fda. gov/NewsEvents/Testimony/ucm204379, htm.
  • 7FDA. Sub Chapter 420-Compendial/Test Requirements Man- ual of Compliance Policy Guides[ S]. 1980.
  • 8FDA. Investigations Operations Manual[ S]. 2010.
  • 9Title 21 Parts 210 and 211 Current Good Manufacturing Practice for Finished Pharmaceuticals. US Code of Federal Regulations [S].2012.
  • 10YU LX. Pharmaceutical quality by design: product and process development, understanding, and control [ J ]. Pharm Res, 2008, 25(4) : 781 -791.

同被引文献314

引证文献16

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部